- Investing Ideas
- Japanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Japanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
2
0 new
Value score of at least 4 focused on companies with a low market cap.
2 companies
WDB coco
Market Cap: JP¥6.3b
Provides contract and human resource services to pharmaceutical companies in Japan.
7079
JP¥2,622.00
7D
0.4%
1Y
-18.7%
Kohjin Bio
Market Cap: JP¥6.5b
Manufactures and sells of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
177A
JP¥1,279.00
7D
4.8%
1Y
-20.1%